// FDA
Butylated Hydroxytoluene (BHT); Request for Information; Reopening of Comment Period
By Editorial Team · Published 2026-07-30
The Food and Drug Administration (FDA or we) is reopening the comment period for the notice titled "Butylated Hydroxytoluene (BHT); Request for Information," which published in the Federal Register of May 13, 2026. We are taking this action in response to a request from stakeholders to extend the comment period to allow additional time for interested parties to develop and submit data, other information, and comments for this request for information.
Primary source: https://www.federalregister.gov/documents/2026/07/30/2026-15429/butylated-hyd...